Akorn Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AKORN, and what generic and branded alternatives to AKORN drugs are available?
AKORN has twenty-six approved drugs.
There are two tentative approvals on AKORN drugs.
Summary for Akorn
US Patents: | 0 |
Tradenames: | 25 |
Ingredients: | 26 |
NDAs: | 26 |
Patent Litigation for Akorn: | See patent lawsuits for Akorn |
PTAB Cases with Akorn as petitioner: | See PTAB cases with Akorn as petitioner |
Drugs and US Patents for Akorn
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akorn | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064028-001 | Jan 30, 1995 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Akorn | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC | bacitracin zinc; neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 065088-001 | Feb 6, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Akorn | OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 204532-001 | Jan 10, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.